Homework Help is Here – Start Your Trial Now!
Science
Biology
Cardiovasculary Problem #6 Problem Part pg T Chapter 10, Problem 43P Disease. A secondary prevention trial of lipid lowering is planned in patients with previous myocardial infarction (MI). Patients are to be randomized to either a treatment group receiving diet therapy and cholesterol- lowering drugs or a control group receiving diet therapy and placebo pills. The study endpoint is to be a combined endpoint consisting of either definite fatal coronary heart disease (CHD) or nonfatal MI (i.e., a new nonfatal MI distinct from previous events). Suppose it is projected that the incidence of combined events among controls is 7% per year. What is the expected event rate in the treated group? Step-by-step solution Step 1/1 The aim is to find the expected event rate in the treated group. The percentage of combined events among controls is 7% The treatment benefit is projected to be reduced to the rate 30% 0.07 Therefore, the expected event rate in the treated group 0.30 This implies, 0.07 0.30 40.2333 p= [] 213 Is the correct answer. Please Explain Hence, the expected event rate in the treated group is 0.2333 Show all steps

Cardiovasculary Problem #6 Problem Part pg T Chapter 10, Problem 43P Disease. A secondary prevention trial of lipid lowering is planned in patients with previous myocardial infarction (MI). Patients are to be randomized to either a treatment group receiving diet therapy and cholesterol- lowering drugs or a control group receiving diet therapy and placebo pills. The study endpoint is to be a combined endpoint consisting of either definite fatal coronary heart disease (CHD) or nonfatal MI (i.e., a new nonfatal MI distinct from previous events). Suppose it is projected that the incidence of combined events among controls is 7% per year. What is the expected event rate in the treated group? Step-by-step solution Step 1/1 The aim is to find the expected event rate in the treated group. The percentage of combined events among controls is 7% The treatment benefit is projected to be reduced to the rate 30% 0.07 Therefore, the expected event rate in the treated group 0.30 This implies, 0.07 0.30 40.2333 p= [] 213 Is the correct answer. Please Explain Hence, the expected event rate in the treated group is 0.2333 Show all steps

Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
See similar textbooks
icon
Related questions
Question
W sabaabbbbbbbbbb :90% ******** Cardiovasculary Disease Chapter 10, Problem 43P Problem www Step 1/1 A secondary prevention trial of lipid lowering is planned in patients with previous myocardial infarction (MI). Patients are to be randomized to either a treatment group receiving diet therapy and cholesterol- lowering drugs or a control group receiving diet therapy and placebo pills. The study endpoint is to be a combined endpoint consisting of either definite fatal coronary heart disease (CHD) or nonfatal MI (i.e., a new nonfatal MI distinct from previous events). Suppose it is projected that the incidence of combined events among controls is 7% per year. What is the expected event rate in the treated group? Step-by-step solution Part 6 (Pgr рут The aim is to find the expected event rate in the treated group. The percentage of combined events among controls is 7% The treatment benefit is projected to be reduced to the rate 30% Therefore, the expected event rate in the treated group This implies, 0.07 0.30 0.07 □ [] Hence, the expected event rate in the treated group is 0.2333 Show all steps 213 Is the correct answer. Please Explain
Transcribed Image Text:W sabaabbbbbbbbbb :90% ******** Cardiovasculary Disease Chapter 10, Problem 43P Problem www Step 1/1 A secondary prevention trial of lipid lowering is planned in patients with previous myocardial infarction (MI). Patients are to be randomized to either a treatment group receiving diet therapy and cholesterol- lowering drugs or a control group receiving diet therapy and placebo pills. The study endpoint is to be a combined endpoint consisting of either definite fatal coronary heart disease (CHD) or nonfatal MI (i.e., a new nonfatal MI distinct from previous events). Suppose it is projected that the incidence of combined events among controls is 7% per year. What is the expected event rate in the treated group? Step-by-step solution Part 6 (Pgr рут The aim is to find the expected event rate in the treated group. The percentage of combined events among controls is 7% The treatment benefit is projected to be reduced to the rate 30% Therefore, the expected event rate in the treated group This implies, 0.07 0.30 0.07 □ [] Hence, the expected event rate in the treated group is 0.2333 Show all steps 213 Is the correct answer. Please Explain
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps with 1 images

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Knowledge Booster
Types of cancer
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education
SEE MORE TEXTBOOKS